Abstract:Protein expression and degradation are fundamental to cell function and physiological status of organisms. Interfering with protein expression not only provides powerful strategies to analyze the function of proteins but also inspires effective treatment methods for diseases caused by protein dysfunction. Recently, harnessing the power of the ubiquitin-proteasome system for targeted protein degradation (TPD) has become the focus of researches. Over the past two decades, TPD technologies, such as E3 ligase modification, PROTACs, and the Trim-Away method, have successfully re-oriented the ubiquitin-proteasome pathway and thus degraded many pathogenic proteins and even "undruggable" targets. However, A low-cost, convenient, and modularized TPD method is currently not available. Herein, we proposed a synthetic biology TPD method, termed Predator, by integrating the classic function of E3 ligase Trim21 and the expression of a bifunctional fusion protein that links Trim21 and the target protein, which leads to the formation of a ternary complex inside mammalian cells and therefore induce the ubiquitination and subsequent proteasome-dependent degradation of the target protein. We first proved this concept by using nanobody and scFv as the targeting module for the Predator system to degrade free GFP and membrane protein ErbB3, respectively. Then, we give an example of how the engineered Predator system can be developed towards biomedical solutions in the context of diabetes mellitus. Ligands-receptor interaction and adenovirus-mediated gene delivery were introduced to the Predator system, and we found this bifunctional fusion protein, in which glucagon was selected to function as the targeting module, downregulated the endogenous glucagon receptor (GCGR) and attenuated glucagon-stimulated glucose production in primary hepatocytes. Although preliminarily, our results showed that this Predator system is a highly modularized and convenient TPD method with good potential for both fundamental researches and clinical usage.

Palladium-Triggered Deprotection Chemistry for Protein Activation in Living Cells

Palladium-Triggered Chemical Rescue of Intracellular Proteins Via Genetically Encoded Allene-Caged Tyrosine

Ligand-free Palladium-Mediated Site-Specific Protein Labeling Inside Gram-Negative Bacterial Pathogens.

Genetically Encoded Bioorthogonal Tryptophan Decaging in Living Cells

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s.

Bioorthogonal Chemical Activation of Kinases in Living Systems.

Diels-Alder Reaction–triggered Bioorthogonal Protein Decaging in Living Cells

Integration of Palladium Nanoparticles with Surface Engineered Metal–Organic Frameworks for Cell-Selective Bioorthogonal Catalysis and Protein Activity Regulation

A Pyridinium-Based Strategy for Lysine-Selective Protein Modification and Chemoproteomic Profiling in Live Cells

Enzyme-catalyzed Activation of Pro-PROTAC for Cell-selective Protein Degradation

New strategy for reversible modulation of protein activity through site-specific conjugation of small molecule and polymer.

A Proximity-Triggered Strategy Toward Transferable Proteolysis Targeting Chimeras

Enzyme-Instructed Activation of Pro-protein Therapeutics in Vivo

Predator: A novel method for targeted protein degradation

Copper-Triggered Bioorthogonal Cleavage Reactions for Reversible Protein and Cell Surface Modifications

Catalyst-Free Late-Stage Functionalization to Assemble α-acyloxyenamide Electrophiles for Selectively Profiling Conserved Lysine Residues

Logic Gate Activated Lysosome Targeting DNA Nanodevice for Controlled Proteins Degradation

Stimuli‐Responsive PROTACs for Controlled Protein Degradation

Catalyst-free thiazolidine formation chemistry enables the facile construction of peptide/protein-cell conjugates (PCCs) at physiological pH

Discovery of novel protein degraders based on bioorthogonal reaction-driven intracellular self-assembly strategy